Liminatus Pharma Inc (LIMN)

Currency in USD
6.780
+0.090(+1.35%)
Closed·
After Hours
7.000+0.220(+3.24%)
·
LIMN Scorecard
Full Analysis
High shareholder yield
LIMN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.6607.100
52 wk Range
4.40033.660
Key Statistics
Prev. Close
6.69
Open
6.78
Day's Range
6.66-7.1
52 wk Range
4.4-33.66
Volume
317.66K
Average Volume (3m)
569.53K
1-Year Change
-38.53%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LIMN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Liminatus Pharma Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Liminatus Pharma Inc Company Profile

Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 2018 is based in LA Palma, California.

Compare LIMN to Peers and Sector

Metrics to compare
LIMN
Peers
Sector
Relationship
P/E Ratio
−49.7x−4.5x−0.5x
PEG Ratio
0.120.020.00
Price/Book
−166,395.5x3.1x2.6x
Price / LTM Sales
-192.4x3.3x
Upside (Analyst Target)
-169.1%42.4%
Fair Value Upside
Unlock8.9%7.2%Unlock

Earnings

Latest Release
Jun 02, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

LIMN Income Statement

People Also Watch

0.99
KLTO
+3.13%
34.40
BMNR
+7.50%
16.75
SRPT
+5.81%
8.800
TRON
-5.27%
2.87
RBNE
-6.51%

FAQ

What Stock Exchange Does Liminatus Pharma Trade On?

Liminatus Pharma is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Liminatus Pharma?

The stock symbol for Liminatus Pharma is "LIMN."

What Is the Liminatus Pharma Market Cap?

As of today, Liminatus Pharma market cap is 176.38M.

What Is Liminatus Pharma's Earnings Per Share (TTM)?

The Liminatus Pharma EPS (TTM) is -0.14.

From a Technical Analysis Perspective, Is LIMN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Liminatus Pharma Stock Split?

Liminatus Pharma has split 0 times.

How Many Employees Does Liminatus Pharma Have?

Liminatus Pharma has 0 employees.

What is the current trading status of Liminatus Pharma (LIMN)?

As of 31 Jul 2025, Liminatus Pharma (LIMN) is trading at a price of 6.78, with a previous close of 6.69. The stock has fluctuated within a day range of 6.66 to 7.10, while its 52-week range spans from 4.40 to 33.66.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.